1. 25-48 of 434 « 1 2 3 4 5 ... 16 17 18 »
    1. ORIC Pharmaceuticals Appoints Lori Kunkel, M.D., to its Board of Directors

      ORIC Pharmaceuticals Appoints Lori Kunkel, M.D., to its Board of Directors

      SOUTH SAN FRANCISCO, Calif., June 09, 2020 (GLOBE NEWSWIRE) -- ORIC Pharmaceuticals, Inc. (Nasdaq: ORIC), a clinical stage oncology company focused on developing treatments that address mechanisms of therapeutic resistance, today announced the appointment of Lori Kunkel, M.D., to its board of directors...

      Read Full Article
    2. Daktronics Board of Directors Announces Nancy Frame's Retirement and Nominates Dr. José-Marie Griffiths to the Board

      Daktronics Board of Directors Announces Nancy Frame's Retirement and Nominates Dr. José-Marie Griffiths to the Board

      Daktronics, Inc. (NASDAQ - DAKT) announces Nancy D. Frame's retirement effective September 2, 2020.  Ms. Frame had served on the Daktronics Board of Directors since 1999.  She also served as the chairperson of the Nominating and Corporate Governance Committee and as Lead Independent Director...

      Read Full Article
    3. GCP Applied Technologies Announces Preliminary Results of 2020 Annual Meeting of Stockholders and Reconstituted Board of Directors

      GCP Applied Technologies Announces Preliminary Results of 2020 Annual Meeting of Stockholders and Reconstituted Board of Directors

      CAMBRIDGE, Mass., May 28, 2020 (GLOBE NEWSWIRE) -- GCP Applied Technologies Inc. (NYSE:GCP) (“GCP” or the “Company”), a leading global provider of construction products technologies, today announced that, based on the preliminary vote count provided by its proxy solicitor following the Company’s 2020 Annual Meeting of Stockholders, GCP shareholders have elected all eight Starboard-nominated directors to GCP’s Board of Directors including: Kevin Brown, Peter Feld, Janet Giesselman, Clay Kiefaber, Marran Ogilvie, Andrew Ross, Linda Welty and Rob Yanker...

      Read Full Article
    4. Myriad Genetics Appoints Daniel K. Spiegelman to the Board of Directors and Announces Upcoming Retirement of John T. Henderson, M.D.

      Myriad Genetics Appoints Daniel K. Spiegelman to the Board of Directors and Announces Upcoming Retirement of John T. Henderson, M.D.

      Myriad Genetics, Inc. (NASDAQ: MYGN), a global leader in molecular diagnostics and precision medicine, today announced the election of Daniel K. Spiegelman, age 61, to its Board of Directors, effective immediately, expanding the Board to nine members...

      Read Full Article
    5. Tuesday Morning Corporation Files Chapter 11 to Pursue Financial and Operational Reorganization

      Tuesday Morning Corporation Files Chapter 11 to Pursue Financial and Operational Reorganization

      Tuesday Morning Corporation (NASDAQ: TUES) today announced it will pursue financial and operational reorganization designed to allow the Company to reduce its outstanding liabilities and strengthen its overall financial position. These actions are in response to the immense strain the COVID-19 pandemic and related store closures have put on the business...

      Read Full Article
    6. MatriSys Bioscience Inc. is Pleased to Announce That Magda Marquet PhD Has Been Appointed Chairwoman of MatriSys’ Board of Directors

      MatriSys Bioscience Inc. is Pleased to Announce That Magda Marquet PhD Has Been Appointed Chairwoman of MatriSys’ Board of Directors

      SAN DIEGO, May 26, 2020 (GLOBE NEWSWIRE) -- MatriSys Bioscience, Inc., a leader in the field of microbiome-based therapeutics, is pleased to announce that Magda Marquet PhD has been appointed Chairwoman of MatriSys’ Board of Directors...

      Read Full Article
    7. SpringWorks Therapeutics Appoints Julie Hambleton, M.D. to its Board of Directors

      SpringWorks Therapeutics Appoints Julie Hambleton, M.D. to its Board of Directors

      STAMFORD, Conn., May 26, 2020 (GLOBE NEWSWIRE) -- SpringWorks Therapeutics, Inc. (Nasdaq: SWTX), a clinical-stage biopharmaceutical company focused on developing life-changing medicines for patients with severe rare diseases and cancer, today announced the appointment of Julie Hambleton, M.D. to the Company’s Board of Directors...

      Read Full Article
    8. GameStop Issues Investor Presentation Highlighting its Progress Driving Value for All Stockholders

      GameStop Issues Investor Presentation Highlighting its Progress Driving Value for All Stockholders

      GameStop Corp. (NYSE: GME) (the “Company”) today announced that it has filed a detailed investor presentation titled “Driving Value for All Stockholders,” highlighting GameStop’s significant recent refreshment of the Board and management, as well as leadership’s successful progress on executing the business transformation plan “GameStop Reboot.”...

      Read Full Article
    25-48 of 434 « 1 2 3 4 5 ... 16 17 18 »
  1. Categories

    1. BoardProspects Features:

      BoardBlogs, BoardKnowledge, BoardMoves, BoardNews, BoardProspects Announcements, BoardProspects CEO, CEO Blog, In the News, Partner Publications, Question of The Week, Sponsored Content